Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-25 @ 2:03 AM
NCT ID:
NCT00235560
Eligibility Criteria:
Inclusion Criteria:
* Informed consent
* de novo or secondary LAM (CML excluded) not elligible for intensive chemotherapy.
* Previously untreated
Exclusion Criteria:
* Renal impairment (serum creatinin \>2N)
* Hepatic impairment (TGO ou TGP \> 5N), une cholestase (Phosphatases Alcalines or gamma-GT \> 5N),bilirubin \> 3N
* Blast crisis CML
* Acute Promyelocytic Leukemia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT00235560
Study Brief:
Protocol Section:
NCT00235560